Table 2: Effects of glucomannan on efficacy outcomes .

Characteristic: mean Glucomannan Control
Baseline2 weeks8 weeksBaseline2 weeks8 weeks

Weight, kg83.75 83.4383.3685.485.384.97
Weight loss, kg−.32−.40−.11−.43
BMI, kg/m2 30.69 30.56 30.64 30.97 30.56 30.66
Waist circum., cm 95.62 94.80 94.42 97.55 96.71 97.30
Hip circum., cm113.90113.66113.26113.56113.65112.28
Fat mass, kg 32.93 33.09 33.31 31.91 32.21 31.91
Fat-free mass, kg51.9951.6651.6650.7150.2649.68
Hunger, mm 43.64 39.10 43.87 42.61 43.48 39.59
Fullness, mm 34.34 48.18 38.86 40.00 45.65 50.00
Cholesterol, mg/dL207.00200.06194.50204.60203.13207.33
HDL, mg/dL 47.81 45.75 48.25 54.40 52.80 52.60
LDL, mg/dL134.00128.94128.12129.47127.47128.73
Triglycerides, mg/dL125.31126.00115.94104.13114.40130.33
Glucose, mg/dL 87.38 82.79 88.06 87.93 89.33 91.00